查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1291477

HPV檢測和PAP檢測市場：2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測

HPV Testing and PAP Test Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

市場概況：

2022年，全球HPV檢測和PAP檢測市場規模達到40億美元。展望未來，IMARC Group預計到2028年市場規模將達到56億美元，在2023-2028年期間表現出5.92%的成長率（CAGR）。

人乳頭瘤病毒（HPV）是一種性傳播感染（STI），會促使宮頸、口咽、陰莖和外陰的癌症。它可以在各種測試和程序的支持下被檢測出來，如HPV和帕帕尼古拉烏（PAP）測試。這些評估包括對標本的顯微鏡觀察和宮頸癌、頭頸癌篩查。其中，HPV測試被部署用於評估在生殖器疣發展之前存在的人類乳頭瘤病毒，而PAP測試則用於確定細胞的變化和宮頸中存在的異常細胞。

HPV檢測和PAP檢測市場趨勢：

由於乳頭瘤病毒的存在，宮頸癌的發病率越來越高，特別是在成年人群中，這促進了對新型的、技術先進的、具有成本效益的HPV和PAP篩查的需求，這也是推動市場成長的主要因素之一。與此相呼應，引入機器輔助的、無血漿和無細胞的脫氧核糖核酸（DNA）篩查，在早期階段檢測和監測感染HPV的癌症的治療反應，是另一個成長誘導因素。由於冠狀病毒病（COVID-19）大流行的突然爆發，主要參與者不斷進行臨床試驗、開發和推出產品，如易於使用的家用HPV篩查測試，正在為他們提供市場競爭優勢。其他因素，如醫療部門的快速擴張，以及政府機構和非政府組織（NGO）為提高人們對宮頸癌病因以及進行HPV和PAP測試的好處的認識而採取的許多有利計劃，正在為市場創造積極的前景。

本報告中回答的關鍵問題：

  • 迄今為止，全球HPV檢測和PAP檢測市場的表現如何，在未來幾年將如何表現？
  • COVID-19對全球HPV檢測和PAP檢測市場的影響是什麼？
  • 主要的區域市場是什麼？
  • 基於測試類型的市場細分是什麼？
  • 基於產品的市場細分是什麼？
  • 基於應用的市場細分是什麼？
  • 基於終端用戶的市場細分是什麼？
  • 行業價值鏈中的各個階段是什麼？
  • 該行業的關鍵驅動因素和挑戰是什麼？
  • 全球HPV檢測和PAP檢測市場的結構是什麼，誰是主要參與者？
  • 該行業的競爭程度如何？

目錄

第一章：前言

第二章：範圍和方法

  • 研究的目標
  • 利益相關者
  • 數據來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章：執行摘要

第四章：簡介

  • 概述
  • 主要行業趨勢

第五章：全球HPV檢測和PAP檢測市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章：按測試類型分類的市場

  • HPV測試
    • 市場趨勢
    • 市場預測
  • 巴氏試驗
    • 市場趨勢
    • 市場預測
  • 聯合檢測
    • 市場趨勢
    • 市場預測

第7章：按產品分類的市場

  • 儀器
    • 市場趨勢
    • 市場預測
  • 耗材
    • 市場趨勢
    • 市場預測
  • 服務
    • 市場趨勢
    • 市場預測

第8章：按應用分類的市場

  • 子宮頸癌篩查
    • 市場趨勢
    • 市場預測
  • 陰道癌篩查
    • 市場趨勢
    • 市場預測

第九章：按終端用戶分類的市場

  • 醫院和診所
    • 市場趨勢
    • 市場預測
  • 實驗室
    • 市場趨勢
    • 市場預測
  • 診斷中心
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第十章：按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳大利亞
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第十一章：SWOT分析

  • 概述
  • 優勢
  • 劣勢
  • 機會
  • 威脅

第十二章：價值鏈分析

第十三章：波特斯五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第十四章：價格分析

第十五章：競爭格局

  • 市場結構
  • 主要參與者
  • 主要參與者的概況
    • Abbott Laboratories
    • Arbor Vita Corporation
    • AstraZeneca plc
    • Becton Dickinson and Company
    • Biocon Limited
    • bioMerieux SA
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Hologic Inc.
    • NURX Inc. (Thirty Madison Inc.)
    • Qiagen NV
    • Quest Diagnostics Incorporated
    • Seegene Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A5889

Market Overview:

The global HPV testing and PAP test market size reached US$ 4.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.6 Billion by 2028, exhibiting a growth rate (CAGR) of 5.92% during 2023-2028. 

Human papillomavirus (HPV) is a sexually transmitted infection (STI) that causes cancer of the cervix, oropharynx, penis, and vulva. It can be detected with the support of various tests and procedures, such as HPV and Papanicolaou (PAP) test. These assessments comprise microscopic observation of specimens and cervical, head and neck cancer screening. Amongst these, HPV tests are deployed for assessing the presence of human papillomavirus that precede the development of genital warts, whereas PAP tests are used for determining changes in the cell and the presence of abnormal cells in cervices. 

HPV Testing and PAP Test Market Trends:

The increasing prevalence of cervical cancer, especially amongst the adult demographics. due to presence of papillomavirus is facilitating the need for novel, technologically advanced, and cost-effective HPV and PAP screening, which is one of the major factors primarily driving the market growth. In line with this, the introduction of machine-assisted, plasma- and cell-free deoxyribonucleic acid (DNA) screenings to detect and monitor the treatment response of HPV-infected cancers at the early phase is acting as another growth-inducing factor. This is further supported by the continuous clinical trials, developments, and product launches by key players, such as the easy-to-use home HPV screening test, on account of the sudden outbreak of coronavirus disease (COVID-19) pandemic, is providing them with a competitive edge in the market. Other factors, such as the rapid expansion in the healthcare sector and the numerous favorable initiatives undertaken by the government bodies and the non-governmental organizations (NGOs) for sensitizing people regarding the causes of cervical cancer and the benefits of having HPV and PAP tests are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global HPV testing and PAP test market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on test type, product, application and end user.

Breakup by Test Type:

  • HPV Test
  • Pap Test
  • Co-testing

Breakup by Product:

  • Instruments
  • Consumables
  • Services

Breakup by Application:

  • Cervical Cancer Screening
  • Vaginal Cancer Screening

Breakup by End User:

  • Hospitals and Clinics
  • Laboratories
  • Diagnostic Centers
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arbor Vita Corporation, AstraZeneca plc, Becton Dickinson and Company, Biocon Limited, bioMerieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., NURX Inc. (Thirty Madison Inc.), Qiagen N.V., Quest Diagnostics Incorporated, Seegene Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global HPV testing and PAP test market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global HPV testing and PAP test market?
  • What are the key regional markets?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global HPV testing and PAP test market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global HPV Testing and PAP Test Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Test Type

  • 6.1  HPV Test
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Pap Test
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Co-testing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7   Market Breakup by Product

  • 7.1  Instruments
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Consumables
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Services
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8   Market Breakup by Application

  • 8.1  Cervical Cancer Screening
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Vaginal Cancer Screening
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9   Market Breakup by End User

  • 9.1  Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2  Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3  Diagnostic Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4  Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10  Market Breakup by Region

  • 10.1  North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2  Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3  Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4  Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5  Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11  SWOT Analysis

  • 11.1  Overview
  • 11.2  Strengths
  • 11.3  Weaknesses
  • 11.4  Opportunities
  • 11.5  Threats

12  Value Chain Analysis

13  Porters Five Forces Analysis

  • 13.1  Overview
  • 13.2  Bargaining Power of Buyers
  • 13.3  Bargaining Power of Suppliers
  • 13.4  Degree of Competition
  • 13.5  Threat of New Entrants
  • 13.6  Threat of Substitutes

14  Price Analysis

15  Competitive Landscape

  • 15.1  Market Structure
  • 15.2  Key Players
  • 15.3  Profiles of Key Players
    • 15.3.1  Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2  Arbor Vita Corporation
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3  AstraZeneca plc
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4  Becton Dickinson and Company
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5  Biocon Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6  bioMerieux SA
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7  Danaher Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8  F. Hoffmann-La Roche AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9  Hologic Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10  NURX Inc. (Thirty Madison Inc.)
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11  Qiagen N.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12  Quest Diagnostics Incorporated
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
    • 15.3.13  Seegene Inc.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
    • 15.3.14  Thermo Fisher Scientific Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials
      • 15.3.14.4 SWOT Analysis

List of Figures

  • Figure 1: Global: HPV Testing and PAP Test Market: Major Drivers and Challenges
  • Figure 2: Global: HPV Testing and PAP Test Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: HPV Testing and PAP Test Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: HPV Testing and PAP Test Market: Breakup by Test Type (in %), 2022
  • Figure 5: Global: HPV Testing and PAP Test Market: Breakup by Product (in %), 2022
  • Figure 6: Global: HPV Testing and PAP Test Market: Breakup by Application (in %), 2022
  • Figure 7: Global: HPV Testing and PAP Test Market: Breakup by End User (in %), 2022
  • Figure 8: Global: HPV Testing and PAP Test Market: Breakup by Region (in %), 2022
  • Figure 9: Global: HPV Testing and PAP Test (HPV Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: HPV Testing and PAP Test (HPV Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: HPV Testing and PAP Test (Pap Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: HPV Testing and PAP Test (Pap Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: HPV Testing and PAP Test (Co-testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: HPV Testing and PAP Test (Co-testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: HPV Testing and PAP Test (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: HPV Testing and PAP Test (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: HPV Testing and PAP Test (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: HPV Testing and PAP Test (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: HPV Testing and PAP Test (Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: HPV Testing and PAP Test (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: HPV Testing and PAP Test (Cervical Cancer Screening) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: HPV Testing and PAP Test (Cervical Cancer Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: HPV Testing and PAP Test (Vaginal Cancer Screening) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: HPV Testing and PAP Test (Vaginal Cancer Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: HPV Testing and PAP Test (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: HPV Testing and PAP Test (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: HPV Testing and PAP Test (Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: HPV Testing and PAP Test (Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: HPV Testing and PAP Test (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: HPV Testing and PAP Test (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: HPV Testing and PAP Test (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: HPV Testing and PAP Test (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: North America: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: North America: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: United States: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: United States: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Canada: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Canada: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Asia-Pacific: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Asia-Pacific: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: China: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: China: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Japan: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Japan: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: India: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: India: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: South Korea: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: South Korea: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Australia: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Australia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Indonesia: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Indonesia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Others: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Europe: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Europe: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Germany: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Germany: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: France: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: France: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: United Kingdom: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: United Kingdom: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Italy: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Italy: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Spain: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Spain: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Russia: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Russia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Others: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Latin America: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Latin America: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Brazil: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Brazil: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Mexico: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Mexico: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Others: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Middle East and Africa: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Middle East and Africa: HPV Testing and PAP Test Market: Breakup by Country (in %), 2022
  • Figure 81: Middle East and Africa: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Global: HPV Testing and PAP Test Industry: SWOT Analysis
  • Figure 83: Global: HPV Testing and PAP Test Industry: Value Chain Analysis
  • Figure 84: Global: HPV Testing and PAP Test Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: HPV Testing and PAP Test Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: HPV Testing and PAP Test Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 3: Global: HPV Testing and PAP Test Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 4: Global: HPV Testing and PAP Test Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: HPV Testing and PAP Test Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: HPV Testing and PAP Test Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: HPV Testing and PAP Test Market: Competitive Structure
  • Table 8: Global: HPV Testing and PAP Test Market: Key Players